<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Hence, the produced BBE presents itself as a compatible system able to be administrated to the buccal mucosa, avoiding discomfort during the administration, since that the buccal mucosa has a pH range between 5.5 and 7.0, fluctuating according to the salivation flow rate [
 <xref rid="B35-pharmaceutics-10-00257" ref-type="bibr" class="xref">35</xref>]. In addition, it is possible that the use of preservatives and antioxidants in the emulsion prevented the microbial contamination and chemical degradation of emulsion components, which could lead to considerable pH decrease [
 <xref rid="B17-pharmaceutics-10-00257" ref-type="bibr" class="xref">17</xref>].
</p>
